{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "12. The method of claim 9 , wherein berbamine of its\n\nanalogue further inhibits the entry of an enterovirus and / or\n\nberbamine has the structure of Formula ( Ilb ) , ( IIIb ) , or\n\n( IVb ) :\n\na lentivirus into the host cells .\n\n13. A method of inhibiting the entry of an enterovirus\n\nFormula ( IIb )\n\nand / or a lentivirus into host cells , comprising contacting the\n\nhost cells with an effective amount of berbamine or its\n\nanalogue , berbamine has a structure of Formula ( I ) :\n\nFormula ( I )\n\nFormula ( IIIb )\n\nOH\n\nOH\n\nor\n\n14. The method of claim 13 , wherein the analogue of\n\nFormula ( IVD )\n\nberbamine has a structure of Formula ( II ) , ( III ) , or ( IV ) :\n\ndog\n\nIH\n\nFormula ( II )\n\n\" 11\n\nNO2\n\nUS 2021/0060002 A1\n\nMar. 4, 2021\n\n12. The method of claim 9, wherein berbamine of its analogue further inhibits the entry of an enterovirus and/or a lentivirus into the host cells.\n\n11. The method of claim 10, wherein the analogue of berbamine has the structure of Formula (IIb), (IIIb), or (IVb):\n\n13. A method of inhibiting the entry of an enterovirus and/or a lentivirus into host cells, comprising contacting the host cells with an effective amount of berbamine or its analogue, berbamine has a structure of Formula (I):\n\nFormula (IIb)\n\nFomnula (1)\n\n14. The method of claim 13, wherein the analogue berbamine has a structure of Formula (II), (IID, or (IV):\n\nFormula (IVb)\n\n(IIIb)\n\nof\n\nFormula (ID\n\nMar. 4 , 2021\n\nUS 2021/0060002 A1\n\n16\n\ncontinued\n\ncontinued\n\nFormula ( III )\n\nFormula ( IIIb )\n\nOH\n\nN\n\nor\n\nor\n\nNO2\n\nFormula ( IV )\n\nFormula ( IV )\n\n??\n\nHIH\n\n15. The method of claim 14 , wherein the analogue of\n\nog\n\nberbamine has a structure of Formula ( IIb ) , ( IIIb ) , or ( IVb ) :\n\nFormula ( IIb )\n\nNO2\n\nH\n\n16. The method of claim 13 , wherein the enterovirus is\n\nEV - A71 .\n\n17. The method of claim 13 , wherein the lentivirus\n\nencodes histone B - RFP .\n\nUS 2021/0060002 A1\n\nMar. 4, 2021\n\n16\n\n-continued\n\n\u516d O xo O Saree AAA\u3002 ~ ry AAA\n\n(IV)\n\nNo OH | \u516d AAA NN nr) CL SQ 0 oN\n\n(IVb)", "type": "Document"}}